以下是根据您提供的文献内容，按照指定格式提取并标准化后的信息：

```json
{
    "Variants Include": [
        {
            "Gene": "PINK1",
            "variants": [
                {
                    "HGVS": "NM_032409.3:c.731C>G",
                    "cDNA Change": {
                        "transcript": "NM_032409.3",
                        "ref": "C",
                        "alt": "G",
                        "position": "731"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "G",
                        "position": "244"
                    },
                    "Description in input context": "c.731C>G (p.A244G)"
                },
                {
                    "HGVS": "NM_032409.3:c.949G>A",
                    "cDNA Change": {
                        "transcript": "NM_032409.3",
                        "ref": "G",
                        "alt": "A",
                        "position": "949"
                    },
                    "Protein Change": {
                        "ref": "V",
                        "alt": "I",
                        "position": "317"
                    },
                    "Description in input context": "c.949G>A (p.V317I)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson's disease",
        "MONDO": "MONDO:0005072"
    },
    "Experiment Method": [
        {
            "Assay Method": "Western Blotting",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "SH-SY5Y neuroblastoma cells",
                "Description": "Human SH-SY5Y neuroblastoma cells were used for the experiment."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_032409.3:c.731C>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "Wild-type PINK1 protected cells from staurosporine-induced apoptosis, while PINK1A244G did not."
                },
                {
                    "Variant": "NM_032409.3:c.949G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "Wild-type PINK1 protected cells from staurosporine-induced apoptosis, while PINK1V317I did not."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "The experiment was replicated in three independent experiments."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was analyzed in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type PINK1 cDNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "2"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "One-way ANOVA with post hoc multiple comparisons using Bonferroni correction was used for statistical analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Less than 36% TUNEL-positive cells under staurosporine treatment.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "More than 36% TUNEL-positive cells under staurosporine treatment.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Fluorometric TUNEL assay",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "SH-SY5Y neuroblastoma cells",
                "Description": "Human SH-SY5Y neuroblastoma cells were used for the experiment."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_032409.3:c.731C>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "Wild-type PINK1 protected cells from staurosporine-induced apoptosis, while PINK1A244G did not."
                },
                {
                    "Variant": "NM_032409.3:c.949G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "Wild-type PINK1 protected cells from staurosporine-induced apoptosis, while PINK1V317I did not."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "The experiment was replicated in three independent experiments."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was analyzed in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type PINK1 cDNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "2"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "One-way ANOVA with post hoc multiple comparisons using Bonferroni correction was used for statistical analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Less than 36% TUNEL-positive cells under staurosporine treatment.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "More than 36% TUNEL-positive cells under staurosporine treatment.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```

### 解释与说明：
1. **变异信息**：从文献中提取了两个PINK1基因的变异（c.731C>G和c.949G>A），并标准化为HGVS命名法。
2. **疾病描述**：研究的疾病是帕金森病，并从MONDO数据库检索到相应的术语。
3. **实验方法**：列出了两种实验方法（Western Blotting 和 Fluorometric TUNEL assay），并详细描述了每种方法的材料来源、读出类型、结果描述、实验重复、对照设置、统计分析方法及正常和异常结果的阈值。
4. **实验验证**：确认实验方法是否通常用于研究该疾病。

以上信息严格遵循了文献内容，并确保数据准确性和一致性。